Lindeman, Neal

Publications

Sort by

Co-Author Network

selected publications

Design and creation of a racially diverse lung cancer registry with detailed genomic and environmental annotation. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2025 Academic Article GET IT
Pan-cancer spatial characterization of key immune biomarkers in the tumor microenvironment. Cell reports. Medicine. 2025 Academic Article GET IT
Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. 2025 Academic Article GET IT
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8⁺ and PD-1⁺ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors. JCO precision oncology. 2025 Academic Article GET IT
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications. American journal of clinical pathology. 2025 Academic Article GET IT
Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations. The Journal of molecular diagnostics : JMD. 2025 Academic Article GET IT
Advancing the Landscape of Clinical Actionability in Von Hippel-Lindau Syndrome: An Evidence-Based Framework from the INT²GRATE Oncology Consortium. Cancers. 2025 Academic Article GET IT
A Concordance Study Among 26 NGS Laboratories Participating in the National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025 Academic Article GET IT
Clinicogenomic characterization of inflammatory breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025 Academic Article GET IT
A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4. Neuro-oncology. 2025 Academic Article GET IT
Comparison of Targeted RNA-Sequencing Platforms for Oncogenic Fusion Detection in Non-Small-Cell Lung Cancer. The Journal of molecular diagnostics : JMD. 2025 Academic Article GET IT
Subareolar sclerosing ductal hyperplasia shows PI3K pathway alterations. Histopathology. 2025 Academic Article GET IT
Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors. Neuro-oncology. 2025 Academic Article GET IT
Times cited: 10
Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. 2024 GET IT
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nature communications. 2024 Academic Article GET IT
Molecular profiling of visible polypoid and invisible conventional intestinal-type low-grade dysplasia in patients with idiopathic inflammatory bowel disease. Journal of clinical pathology. 2024 Academic Article GET IT
Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer. The Journal of molecular diagnostics : JMD. 2024 Review GET IT
Times cited: 4
Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples. Diagnostic pathology. 2024 Academic Article GET IT
Times cited: 3
Clinicogenomic characterization of inflammatory breast cancer. 2024 GET IT
HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer. American journal of clinical pathology. 2024 Academic Article GET IT
Times cited: 2
SPOT/Dx Pilot Reanalysis and College of American Pathologists Proficiency Testing for KRAS and NRAS Demonstrate Excellent Laboratory Performance. Archives of pathology & laboratory medicine. 2024 Academic Article GET IT
Times cited: 2
Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastoma. 2024 GET IT
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. 2023 GET IT
Times cited: 1
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature communications. 2023 Academic Article GET IT
Times cited: 43
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. JCO oncology practice. 2023 Academic Article GET IT
Times cited: 3
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Molecular cancer therapeutics. 2023 Academic Article GET IT
Times cited: 34
Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends. Archives of pathology & laboratory medicine. 2023 Academic Article GET IT
Times cited: 6
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. JCO precision oncology. 2023 Academic Article GET IT
Times cited: 15
Proliferating Pilar Tumors Are Characterized by Recurrent 15q, 6q, and 6p22.2 Alterations. The American Journal of dermatopathology. 2022 Academic Article GET IT
Times cited: 5
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. JCO precision oncology. 2022 Academic Article GET IT
MatchMiner: an open-source platform for cancer precision medicine. NPJ precision oncology. 2022 Academic Article GET IT
Times cited: 21
Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Advanced Colorectal Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2022 Academic Article GET IT
Times cited: 5
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer. JCO precision oncology. 2022 Academic Article GET IT
Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. Neuro-oncology. 2022 Academic Article GET IT
Times cited: 3
Tiered Somatic Variant Classification Adoption Has Increased Worldwide With Some Practice Differences Based on Location and Institutional Setting. Archives of pathology & laboratory medicine. 2022 Academic Article GET IT
Times cited: 3
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nature medicine. 2022 Academic Article GET IT
Times cited: 47
An optimized protocol for evaluating pathogenicity of VHL germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variants. MethodsX. 2022 Academic Article GET IT
Times cited: 6
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program. Clinical cancer research : an official journal of the American Association for Cancer Research. 2022 Academic Article GET IT
Times cited: 11
Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn. Blood advances. 2022 Academic Article GET IT
Times cited: 2
Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors. Archives of pathology & laboratory medicine. 2022 Academic Article GET IT
Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors. The American journal of surgical pathology. 2022 Academic Article GET IT
Times cited: 12
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis. IEEE transactions on medical imaging. 2022 Academic Article GET IT
Times cited: 390
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Academic Article GET IT
Times cited: 147
Vulvar Melanoma in association with germline MITF p.E318K variant. Cancer genetics. 2022 Academic Article GET IT
Times cited: 3
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor. JCO precision oncology. 2021 Academic Article GET IT
Times cited: 27
Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic data. Data in brief. 2021 Academic Article GET IT
Times cited: 5
Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing. JCO precision oncology. 2021 Academic Article GET IT
Times cited: 14
Author Correction: Fatty acid synthesis is required for breast cancer brain metastasis. 2021 GET IT
Times cited: 5
Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results. European journal of medical genetics. 2021 Academic Article GET IT
Times cited: 6
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. Neuro-oncology. 2021 Academic Article GET IT
Times cited: 123
An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies. Archives of pathology & laboratory medicine. 2021 Academic Article GET IT
Times cited: 2
How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned. The journal of applied laboratory medicine. 2021 Academic Article GET IT
Times cited: 17
Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis. 2021 GET IT
Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAF^V600E -Driven Papillary Thyroid Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Academic Article GET IT
Times cited: 36
FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS. Nature cancer. 2021 Academic Article GET IT
Times cited: 242
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. Cancer discovery. 2021 Academic Article GET IT
Times cited: 29
Practical Considerations Relating to Routine Clinical Biomarker Testing for Non-small Cell Lung Cancer: Focus on Testing for RET Fusions. Frontiers in medicine. 2021 Review GET IT
Times cited: 10
Novel Pathogenic Germline Variant of the Adenomatous Polyposis Coli (APC) Gene, p.S2627Gfs*12 Identified in a Mild Phenotype of APC-Associated Polyposis: A Case Report. 2020 GET IT
Times cited: 5
Genomic Characterization of de novo Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 35
Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2020 Academic Article GET IT
Times cited: 37
Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups. The American journal of surgical pathology. 2020 Academic Article GET IT
Times cited: 30
Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2020 Academic Article GET IT
Times cited: 12
Morphologic, Immunohistochemical, and Molecular Distinction Between Fibroepithelioma of Pinkus and "Fenestrated" Basal Cell Carcinoma. The American Journal of dermatopathology. 2020 Academic Article GET IT
Times cited: 14
Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms. The Journal of molecular diagnostics : JMD. 2020 Academic Article GET IT
Times cited: 23
Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 150
Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies. Archives of pathology & laboratory medicine. 2020 Academic Article GET IT
Times cited: 6
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma. British journal of cancer. 2019 Academic Article GET IT
Times cited: 67
Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 7
Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO). International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2019 Academic Article GET IT
Times cited: 34
Utility of Histologic and Histochemical Screening for 16S Ribosomal RNA Gene Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue for Bacterial Endocarditis. American journal of clinical pathology. 2019 Academic Article GET IT
Times cited: 8
Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 188
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. The Lancet. Oncology. 2019 Academic Article GET IT
Times cited: 411
Targeted Cancer Next-Generation Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract Cancers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2019 Academic Article GET IT
Times cited: 18
Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Archives of pathology & laboratory medicine. 2019 Academic Article GET IT
Times cited: 15
Utility of a Simple and Robust Flow Cytometry Assay for Rapid Clonality Testing in Mature Peripheral T-Cell Lymphomas. American journal of clinical pathology. 2019 Academic Article GET IT
Times cited: 38
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer. 2019 GET IT
Times cited: 23
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges. Neuro-oncology. 2019 Review GET IT
Times cited: 247
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 2019 Academic Article GET IT
Times cited: 317
POLE-mutated clear cell cervical cancer associated with in-utero diethylstilbestrol exposure. 2019 GET IT
Times cited: 8
Clinicopathologic and genetic characteristics of interval colorectal carcinomas favor origin from missed or incompletely excised precursors. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2018 Academic Article GET IT
Times cited: 13
Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma. JCO precision oncology. 2018 Academic Article GET IT
Times cited: 18
Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays. Archives of pathology & laboratory medicine. 2018 Academic Article GET IT
Times cited: 33
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro-oncology. 2018 Academic Article GET IT
Times cited: 98
Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2018 Academic Article GET IT
Times cited: 55
Durable response in a woman with recurrent low-grade endometrioid endometrial cancer and a germline BRCA2 mutation treated with a PARP inhibitor. 2018 GET IT
Times cited: 24
Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing. JAMA oncology. 2018 Academic Article GET IT
Times cited: 38
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2018 Academic Article GET IT
Times cited: 133
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors. The oncologist. 2018 Academic Article GET IT
Times cited: 18
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Archives of pathology & laboratory medicine. 2018 Review GET IT
Times cited: 124
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Review GET IT
Times cited: 694
Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Endocrine pathology. 2018 Academic Article GET IT
Times cited: 18
Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2018 Academic Article GET IT
Times cited: 47
Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract. The American journal of surgical pathology. 2018 Academic Article GET IT
Times cited: 129
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2018 Guideline GET IT
Times cited: 416
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. The Journal of molecular diagnostics : JMD. 2018 Guideline GET IT
Times cited: 276
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Archives of pathology & laboratory medicine. 2018 Guideline GET IT
Times cited: 649
Authors' Reply. The Journal of molecular diagnostics : JMD. 2018 Letter GET IT
Times cited: 2
Worldwide Frequency of Commonly Detected EGFR Mutations. Archives of pathology & laboratory medicine. 2017 Academic Article GET IT
Times cited: 146
A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices. Archives of pathology & laboratory medicine. 2017 Academic Article GET IT
Times cited: 25
Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites. Oncotarget. 2017 Academic Article GET IT
Times cited: 12
HPV-16 in a distinct subset of oral epithelial dysplasia. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2017 Academic Article GET IT
Times cited: 52
Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors. Neuro-oncology. 2017 Academic Article GET IT
Times cited: 75
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma. Neuro-oncology. 2017 Academic Article GET IT
Times cited: 24
The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice. Blood. 2017 Review GET IT
Times cited: 51
Reporting Results of Molecular Tests: A Retrospective Examination of BRAF Mutation Reporting. Archives of pathology & laboratory medicine. 2017 Academic Article GET IT
Times cited: 4
Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. Archives of pathology & laboratory medicine. 2017 Academic Article GET IT
Times cited: 395
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations. Thyroid : official journal of the American Thyroid Association. 2017 Academic Article GET IT
Times cited: 81
Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Review GET IT
Times cited: 43
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study. Genetics in medicine : official journal of the American College of Medical Genetics. 2017 Academic Article GET IT
Times cited: 42
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. The Journal of molecular diagnostics : JMD. 2017 Guideline GET IT
Times cited: 1576
The fuzzy world of precision medicine: deliberations of a precision medicine tumor board. Personalized medicine. 2016 Academic Article GET IT
Times cited: 19
Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI insight. 2016 Academic Article GET IT
Times cited: 366
Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. The Journal of molecular diagnostics : JMD. 2016 Academic Article GET IT
Times cited: 129
Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Academic Article GET IT
Times cited: 72
Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma. The Journal of clinical endocrinology and metabolism. 2016 Academic Article GET IT
Times cited: 30
The Clinical Implications of Inconsistently Methylated Results from Glioblastoma MGMT Testing by Replicate Methylation-Specific PCR. The Journal of molecular diagnostics : JMD. 2016 Academic Article GET IT
Times cited: 15
Primary Endometrial Marginal Zone Lymphoma (MALT Lymphoma): A Unique Clinicopathologic Entity. The American journal of surgical pathology. 2016 Academic Article GET IT
Times cited: 5
Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology. Diagnostic cytopathology. 2016 Academic Article GET IT
Times cited: 56
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine. Genome medicine. 2016 Academic Article GET IT
Times cited: 157
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies. The Journal of molecular diagnostics : JMD. 2016 Academic Article GET IT
Times cited: 149
Molecular testing of different cytologic preparations in patients with advanced lung adenocarcinoma: which yields the best results?. Journal of the American Society of Cytopathology. 2016 Academic Article GET IT
Times cited: 5
Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant. Leukemia & lymphoma. 2016 Letter GET IT
Times cited: 44
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Academic Article GET IT
Times cited: 31
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study. JAMA oncology. 2016 Academic Article GET IT
Times cited: 183
Evaluation for High-risk HPV in Squamous Cell Carcinomas and Precursor Lesions Arising in the Conjunctiva and Lacrimal Sac. The American journal of surgical pathology. 2016 Academic Article GET IT
Times cited: 60
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva. JAMA oncology. 2016 Academic Article GET IT
Times cited: 123
Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study. Genetics in medicine : official journal of the American College of Medical Genetics. 2016 Academic Article GET IT
Times cited: 114
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 Academic Article GET IT
Times cited: 76
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 50
Training the Future Leaders in Personalized Medicine. Journal of personalized medicine. 2016 Academic Article GET IT
Times cited: 14
PIK3CA Mutations are Common in Many Tumor Types and are Often Associated With Other Driver Mutations. Applied immunohistochemistry & molecular morphology : AIMM. 2016 Academic Article GET IT
Times cited: 8
Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 Academic Article GET IT
Times cited: 77
Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing. 2015 GET IT
Times cited: 7
Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality. JAMA oncology. 2015 Academic Article GET IT
Times cited: 6
Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay. Cold Spring Harbor molecular case studies. 2015 Academic Article GET IT
Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 Academic Article GET IT
Times cited: 117
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clinical epigenetics. 2015 Academic Article GET IT
Times cited: 48
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation. Cancer immunology research. 2015 Academic Article GET IT
Times cited: 63
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans. Molecular cancer therapeutics. 2015 Academic Article GET IT
Times cited: 48
Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2015 Academic Article GET IT
Times cited: 32
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro-oncology. 2015 Academic Article GET IT
Times cited: 43
Marketing of personalized cancer care on the web: an analysis of Internet websites. Journal of the National Cancer Institute. 2015 Academic Article GET IT
Times cited: 18
Novel molecular insights from routine genotyping of colorectal carcinomas. Human pathology. 2015 Academic Article GET IT
Times cited: 24
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2014 Academic Article GET IT
Times cited: 847
The Cancer Genomics Resource List 2014. Archives of pathology & laboratory medicine. 2014 Academic Article GET IT
Times cited: 16
BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers. Nucleic acids research. 2014 Academic Article GET IT
Times cited: 156
Targeted genomic analysis of Müllerian adenosarcoma. The Journal of pathology. 2014 Academic Article GET IT
Times cited: 76
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 90
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget. 2014 Academic Article GET IT
Times cited: 53
Prospective enterprise-level molecular genotyping of a cohort of cancer patients. The Journal of molecular diagnostics : JMD. 2014 Academic Article GET IT
Times cited: 77
Bio-inspired cryo-ink preserves red blood cell phenotype and function during nanoliter vitrification. Advanced materials (Deerfield Beach, Fla.). 2014 Academic Article GET IT
Times cited: 51
Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis. 2014 Review GET IT
Times cited: 38
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nature medicine. 2014 Academic Article GET IT
Times cited: 461
Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Leukemia. 2014 Academic Article GET IT
Times cited: 90
Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. 2014 GET IT
Times cited: 15
Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lung. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2013 Academic Article GET IT
Times cited: 42
An improved algorithm for activated protein C resistance and factor V Leiden screening. American journal of clinical pathology. 2013 Academic Article GET IT
Times cited: 13
The role of MGMT testing in clinical practice: a report of the association for molecular pathology. The Journal of molecular diagnostics : JMD. 2013 Review GET IT
Times cited: 61
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2013 Guideline GET IT
Times cited: 746
Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung. Archives of pathology & laboratory medicine. 2013 Academic Article GET IT
Times cited: 12
A unique PML-RARα rearrangement involving chromosomes 11, 15, and 17 in a patient with acute promyelocytic leukemia. Experimental hematology. 2013 Letter GET IT
Times cited: 2
Refrigeration is not necessary for measurement of uric acid in patients treated with rasburicase. Clinical chemistry and laboratory medicine. 2013 Academic Article GET IT
Times cited: 7
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. The Journal of molecular diagnostics : JMD. 2013 Guideline GET IT
Times cited: 405
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Archives of pathology & laboratory medicine. 2013 Guideline GET IT
Times cited: 401
Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemia. Clinical lymphoma, myeloma & leukemia. 2013 Review GET IT
Times cited: 10
Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemia. Clinical lymphoma, myeloma & leukemia. 2013 Academic Article GET IT
Times cited: 11
Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas. 2013 GET IT
Times cited: 143
Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2013 Academic Article GET IT
Times cited: 331
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood. 2013 Academic Article GET IT
Times cited: 361
The introduction of systematic genomic testing for patients with non-small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2012 Academic Article GET IT
Times cited: 97
Molecular diagnostics of lung cancers at the Brigham and Women's Hospital and Dana-Farber Cancer Institute: technology in rapid evolution. Archives of pathology & laboratory medicine. 2012 Academic Article GET IT
Times cited: 7
No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections. American journal of clinical pathology. 2012 Academic Article GET IT
Times cited: 37
The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 168
Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas. The Journal of molecular diagnostics : JMD. 2011 Academic Article GET IT
Times cited: 80
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors. Cancer research. 2011 Academic Article GET IT
Times cited: 563
Serial serum free light chain measurements do not detect changes in disease status earlier than electrophoretic M-spike measurements in patients with intact immunoglobulin myeloma. Clinica chimica acta; international journal of clinical chemistry. 2010 Academic Article GET IT
Times cited: 9
Polylactide-cyclosporin A nanoparticles for targeted immunosuppression. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2010 Academic Article GET IT
Times cited: 82
EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry. American journal of clinical pathology. 2010 Academic Article GET IT
Times cited: 103
A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 407
Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. The Journal of molecular diagnostics : JMD. 2010 Academic Article GET IT
Times cited: 127
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer cell. 2010 Academic Article GET IT
Times cited: 951
Amplification of chromosomal segment 4q12 in non-small cell lung cancer. Cancer biology & therapy. 2009 Academic Article GET IT
Times cited: 84
No evidence for the JAK2 (V617F) or JAK2 exon 12 mutations in primary mediastinal large B-cell lymphoma. Diagnostic molecular pathology : the American journal of surgical pathology, part B. 2009 Academic Article GET IT
Times cited: 9
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 660
EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer. Cancer. 2009 Academic Article GET IT
Times cited: 159
Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 111
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 924
Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male. Hepatology international. 2008 Academic Article GET IT
Times cited: 30
Intravascular cytotoxic T-cell lymphoma: A case report and review of the literature. Journal of the American Academy of Dermatology. 2008 Review GET IT
Times cited: 38
Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007 Academic Article GET IT
Times cited: 975
Immunosuppressant monitoring can be performed by UPLC-Tandem Mass Spectrometry in half the time needed for conventional HPLC-Tandem Mass Spectrometry, with comparable analytical performance. Clinica chimica acta; international journal of clinical chemistry. 2007 Letter GET IT
Times cited: 4
LKB1 modulates lung cancer differentiation and metastasis. Nature. 2007 Academic Article GET IT
Times cited: 890
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy. Cancer cell. 2007 Academic Article GET IT
Times cited: 206
Selecting automation for the clinical chemistry laboratory. Archives of pathology & laboratory medicine. 2007 Academic Article GET IT
Times cited: 38
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science (New York, N.Y.). 2007 Academic Article GET IT
Times cited: 4181
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 315
Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib. 2006 GET IT
Times cited: 237
Epidermal growth factor receptor mutation testing in the care of lung cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Review GET IT
Times cited: 77
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 545
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nature medicine. 2006 Academic Article GET IT
Times cited: 298
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 199
A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma. Japanese journal of clinical oncology. 2006 Academic Article GET IT
Times cited: 62
Copy number variants and pharmacogenomics. Pharmacogenomics. 2006 Review GET IT
Times cited: 46
Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 105
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations. Journal of the National Cancer Institute. 2005 Academic Article GET IT
Times cited: 294
One patient, two lymphomas. Simultaneous primary gastric marginal zone lymphoma and primary duodenal follicular lymphoma. 2004 GET IT
Times cited: 21
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (New York, N.Y.). 2004 Academic Article GET IT
Times cited: 8940
Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissection. Diagnostic molecular pathology : the American journal of surgical pathology, part B. 2002 Academic Article GET IT
Times cited: 19
Effectiveness of sequencing connexin 26 (GJB2) in cases of familial or sporadic childhood deafness referred for molecular diagnostic testing. Genetics in medicine : official journal of the American College of Medical Genetics. 2002 Academic Article GET IT
Times cited: 62
Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression. Urology. 2002 Academic Article GET IT
Times cited: 27

more ...

less ...

Background

education and training

M.D., University of Rochester School of Medicine and Dentistry 94
B.A., Williams College 1990

Contact

full name

Neal Lindeman

primary email

nel4003@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Neal Lindeman Professor of Pathology and Laboratory Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage